Shares of Herbalife Ltd. (NYSE:HLF – Get Free Report) have earned an average recommendation of “Hold” from the five analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $9.90.
A number of brokerages have commented on HLF. B. Riley reduced their price target on Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, October 31st. Mizuho upped their target price on shares of Herbalife from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Friday, November 1st. StockNews.com raised Herbalife from a “hold” rating to a “buy” rating in a report on Monday, November 4th. Finally, DA Davidson restated a “neutral” rating and issued a $7.50 price objective on shares of Herbalife in a research report on Thursday.
View Our Latest Research Report on HLF
Herbalife Stock Up 3.1 %
Herbalife (NYSE:HLF – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.28. Herbalife had a negative return on equity of 20.78% and a net margin of 5.09%. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.19 billion. As a group, equities research analysts anticipate that Herbalife will post 1.57 EPS for the current fiscal year.
Hedge Funds Weigh In On Herbalife
Institutional investors have recently modified their holdings of the stock. Mackenzie Financial Corp purchased a new stake in shares of Herbalife in the 4th quarter worth $960,000. Public Employees Retirement System of Ohio raised its holdings in shares of Herbalife by 341.0% in the fourth quarter. Public Employees Retirement System of Ohio now owns 149,476 shares of the company’s stock valued at $1,000,000 after acquiring an additional 115,578 shares in the last quarter. PharVision Advisers LLC purchased a new stake in Herbalife in the fourth quarter worth about $720,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Herbalife by 21.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 204,157 shares of the company’s stock worth $1,366,000 after acquiring an additional 35,948 shares in the last quarter. Finally, Two Sigma Advisers LP increased its position in Herbalife by 1,583.5% during the 4th quarter. Two Sigma Advisers LP now owns 173,400 shares of the company’s stock valued at $1,160,000 after purchasing an additional 163,100 shares during the period.
About Herbalife
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Further Reading
- Five stocks we like better than Herbalife
- Top Stocks Investing in 5G Technology
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How to Evaluate a Stock Before Buying
- DuPont’s Electronics Spinoff: The Start of Something Big
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.